[Pharmacological profile and clinical efficacy of olopatadine hydrochloride ophthalmic solution (Patanol 0.1% ophthalmic solution)]

Nihon Yakurigaku Zasshi. 2007 Sep;130(3):221-31. doi: 10.1254/fpj.130.221.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Capillary Permeability / drug effects
  • Clinical Trials as Topic
  • Conjunctivitis, Allergic / drug therapy*
  • Cytokines / metabolism
  • Dibenzoxepins / adverse effects
  • Dibenzoxepins / pharmacology*
  • Dibenzoxepins / therapeutic use*
  • Histamine Antagonists
  • Humans
  • Hypersensitivity, Immediate / drug therapy
  • Inflammation Mediators / metabolism
  • Olopatadine Hydrochloride
  • Ophthalmic Solutions
  • Passive Cutaneous Anaphylaxis / drug effects
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Cytokines
  • Dibenzoxepins
  • Histamine Antagonists
  • Inflammation Mediators
  • Ophthalmic Solutions
  • Tumor Necrosis Factor-alpha
  • Olopatadine Hydrochloride